CoChat

Minocycline Augmentation of Pharmacotherapy in Obsessive-Compulsive Disorder: An Open-Label Trial

Open access
Rodriguez, Carolyn I., Bender, James, Marcus, Sue M., Snape, Michael, Rynn, Moira, Simpson, Helen Blair · 2010 · The Journal of Clinical Psychiatry
Cited by 56

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

To the Editor: Most obsessive-compulsive disorder (OCD) patients treated with serotonin reuptake inhibitors (SRIs) show only partial reduction of symptoms.1 Data suggest that OCD may be caused in part by glutamatergic dysfunction in orbitofrontal/basal ganglia brain circuits, 2,3 and prior trials of glutamate modulators (eg, riluzole, memantine) given as augmentation to SRIs suggest that from 30% to 54% of OCD patients respond.[4][5][6][7][8] We conducted a 12-week, prospective, open-label study to assess whether SRI augmentation with minocycline, a tetracycline derivative with putative glutamate-modulating activity (ie, enhancing glial glutamate transport) 9 in addition to its antibiotic properties, would improve OCD symptoms.Advantages of minocycline include low cost (riluzole is expensive) and US Food and Drug Administration (FDA) approval in adults and children > 12 years (memantine is FDA approved only in adults).Minocycline is the most widely prescribed antibiotic for chronic acne because its antibiotic resistance is lower than those of other tetracyclines and antimicrobials.10 It has an excellent side

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4088/jcp.09l05805blu

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 56

Metadata

Authors
Rodriguez, C. I., Bender, J., Marcus, S. M., Snape, M., Rynn, M., & Simpson, H. B.
Venue
The Journal of Clinical Psychiatry
Published
2010-09-15
Volume
71
Issue
09
Pages
1247-1249
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2037258739
Cited by
56
References
6
FWCI
2.37
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.